Purchase Order 75N91019P00681

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,260.00 on August 31, 2020, for biological and reagent material with a firm fixed price. Place of performance is Marshallton, Delaware, with an ultimate completion date of September 30, 2020. The order was not set-aside and reflects full and open competition.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $13,097.50 on May 21, 2021, for biologicals and reagents with an ultimate completion date of June 4, 2021. No set-aside was used. Performance occurs in Marshallton, Delaware. The order is firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $24,998.51 in scientific laboratory equipment on March 11, 2021, with an ultimate completion date of May 31, 2021. Performance takes place in Marshallton, Delaware. The order is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,260.00 on November 9, 2020, for biological and reagent material. Place of performance is Marshtonlon, Delaware. The order carries a firm fixed price and an ultimate completion date of December 30, 2020.</p>

The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $12,904.00, with an award date of August 22, 2017 and ultimate completion on September 22, 2017. Performance takes place in Marshallton, Delaware. The order is a firm fixed price procurement for analytical laboratory equipment or consumables, consistent with Agilent's role as a supplier of gas chromatography-mass spectrometry systems, liquid chromatography-mass spectrometry equipment, and associated...

<p>The National Cancer Institute issued a purchase order to Agilent Technologies Inc. on May 12, 2021, for biologicals and reagents, with a firm fixed price ceiling of $13,097.50 and an ultimate completion date of June 9, 2021. Performance occurs in Marshallton, Delaware. No set-aside designation applies to this order.</p>

The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $18,781.20 on May 31, 2018, with an ultimate completion date of May 31, 2019. No set-aside was used. Performance takes place in Marshallton, Delaware. The order is for firm fixed price supply of analytical laboratory instruments and associated consumables from Agilent's Customer Service and Sales Division, a manufacturer of gas chromatography-mass spectrometry systems, liquid chromatography-mass...

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $10,972.00 on September 8, 2017, with ultimate completion on October 23, 2017. Performance took place in Marshallton, Delaware. The order was firm fixed price with no set-aside. The source does not specify the procurement's scope or originating solicitation.</p>

<p>The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $13,570.50 on July 6, 2020, for drugs and biologicals, with completion on August 6, 2020. Work is performed at Marshtonlon, Delaware. The order carries firm fixed price terms with no set-aside designation.</p>

<p>The National Cancer Institute issued a purchase order to Agilent Technologies Inc. on February 7, 2014, valued at $4,075.65, with completion by February 28, 2015. Performance occurs at Marshallton, Delaware. The order carries no set-aside designation and uses firm fixed pricing.</p>